By contrast, in HLA-A*03:01+ patients with cancers harboring either WT PIK3CA or a PIK3CA mutation that does not generate a public NeoAg, HLA-A LOH events were randomly divided between HLA-A*03:01 and the alternative HLA-A allele. Here, PIK3CA is linked to cancer.